Diaceutics
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	£13.94M N/A	£19.50M 39.88%	£23.69M 21.50%	Avg: £37.85M Low: £36.29M High: £38.99M avg. 59.73%	Avg: £46.76M Low: £45.28M High: £47.91M avg. 23.53%	Avg: £58.17M Low: £56.33M High: £59.60M avg. 24.40%
Net Income % change YoY	£561K N/A	£724K 29.05%	£-1.74M -341.16%	Avg: £482K Low: £-471.67K High: £1.79M avg. 127.60%	Avg: £4.71M Low: £2.85M High: £5.80M avg. 877.17%	Avg: £7.48M Low: £7.17M High: £7.72M avg. 58.97%
EBITDA % change YoY	£2.11M N/A	£3.33M 58.09%	£2.35M -29.35%	Avg: £4.57M Low: £4.38M High: £4.71M avg. 93.85%	Avg: £5.64M Low: £5.47M High: £5.78M avg. 23.53%	Avg: £7.02M Low: £6.80M High: £7.20M avg. 24.40%
EPS % change YoY	$0.01 N/A	$0.01 28.35%	-$0.02 -340.69%	Avg: $0.01 Low: -$0.01 High: $0.02 avg. 151.69%	Avg: $0.05 Low: $0.03 High: $0.07 avg. 405.32%	Avg: $0.09 Low: $0.09 High: $0.09 avg. 64.41%
Operating Expenses % change YoY	£10.25M N/A	£13.70M 33.67%	£22.72M 65.79%	Avg: £27.16M Low: £26.05M High: £27.98M avg. 19.55%	Avg: £33.56M Low: £32.49M High: £34.38M avg. 23.53%	Avg: £41.75M Low: £40.43M High: £42.78M avg. 24.40%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 354.58% in 2025-2027.

We have gathered data from 3 analysts. Their low estimate is -471.67K, average is 482K and high is 1.79M.

Wall Street analysts forecast annual average revenue growth of 35.89% in 2025-2027.

We have gathered data from 5 analysts. Their low revenue estimate is £36.29M, average is £37.85M and high is £38.99M.

Wall Street analysts forecast annual average earnings growth of 207.14% in 2025-2027.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.01, average is $0.01 and high is £0.02.